US Stock MarketDetailed Quotes

TRML Tourmaline Bio

Watchlist
  • 13.770
  • +0.250+1.85%
Close May 31 16:00 ET
  • 13.860
  • +0.090+0.65%
Post 19:38 ET
353.15MMarket Cap-6648P/E (TTM)

Tourmaline Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tourmaline Bio Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.55

-49.10%
Analyst Rating

Strong Buy

May 31, 2024

Tourmaline Bio Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Tourmaline Bio Earnings Reports

  • Tourmaline Bio | 10-Q: Quarterly report

    May 14 04:20

  • Tourmaline Bio | 10-K: Annual report

    Mar 20 05:07

  • Tourmaline Bio | 10-Q: Quarterly report

    Nov 15, 2023 06:12

  • Talaris Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 14, 2023 19:53

    • Read more

    Analysis

    Analyst Rating

    Updated: May 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg